Doximity, Inc. (DOCS) stock
DOCSNYSEServices-Computer Programming ServicesFiscal year ends March 31
Financials through Q2 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 15/3022% above fair value
$33.22+0.80 (+2.47%)
Close on Nov 11, 2026Market cap $5.92BP/E 46.1Yield –
Doximity r&d expenses
Research and development expenses are spending on new products and technology.
Doximity's R&D Expenses for the twelve months ending Sep 30, 2026 was $154.14M, up 47.9% year over year. For fiscal 2026 it was $130.70M, up 40.5% from the year before. The highest annual figure on record is $130.70M in fiscal 2026.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | $130.70M | +40.5% |
| FY2025 | Mar 31, 2025 | $93.04M | +13.5% |
| FY2024 | Mar 31, 2024 | $81.98M | +2.2% |
| FY2023 | Mar 31, 2023 | $80.19M | +28.6% |
| FY2022 | Mar 31, 2022 | $62.35M | +42.1% |
| FY2021 | Mar 31, 2021 | $43.87M | +35.3% |
| FY2020 | Mar 31, 2020 | $32.44M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2027CQ3 2026 | Sep 30, 2026 | $41.96M | +38.9% |
| Q1 FY2027CQ2 2026 | Jun 30, 2026 | $38.48M | +43.6% |
| Q4 FY2026CQ1 2026 | Mar 31, 2026 | $39.11M | +57.7% |
| Q3 FY2026CQ4 2025 | Dec 31, 2025 | $34.60M | +54.3% |
| Q2 FY2026CQ3 2025 | Sep 30, 2025 | $30.20M | +30.0% |
| Q1 FY2026CQ2 2025 | Jun 30, 2025 | $26.80M | +18.7% |
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | $24.80M | +23.1% |
| Q3 FY2025CQ4 2024 | Dec 31, 2024 | $22.42M | +12.4% |
| Q2 FY2025CQ3 2024 | Sep 30, 2024 | $23.24M | +16.4% |
| Q1 FY2025CQ2 2024 | Jun 30, 2024 | $22.57M | +2.9% |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | $20.15M | -6.5% |
| Q3 FY2024CQ4 2023 | Dec 31, 2023 | $19.95M | -2.8% |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | $19.96M | +4.5% |
| Q1 FY2024CQ2 2023 | Jun 30, 2023 | $21.93M | +15.3% |
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | $21.54M | +23.6% |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | $20.52M | +26.5% |
| Q2 FY2023CQ3 2022 | Sep 30, 2022 | $19.10M | +23.6% |
| Q1 FY2023CQ2 2022 | Jun 30, 2022 | $19.02M | +43.7% |
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | $17.42M | +38.7% |
| Q3 FY2022CQ4 2021 | Dec 31, 2021 | $16.23M | +42.2% |
| Q2 FY2022CQ3 2021 | Sep 30, 2021 | $15.46M | +56.7% |
| Q1 FY2022CQ2 2021 | Jun 30, 2021 | $13.24M | +31.8% |
| Q4 FY2021CQ1 2021 | Mar 31, 2021 | $12.56M | – |
| Q3 FY2021CQ4 2020 | Dec 31, 2020 | $11.41M | – |
| Q2 FY2021CQ3 2020 | Sep 30, 2020 | $9.87M | – |
| Q1 FY2021CQ2 2020 | Jun 30, 2020 | $10.04M | – |
See a number that looks wrong?